Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
REMEDY Science closes a significant Series A funding round, raising $20 million led by L Catterton, with participation from Sonoma Brands Capital and Norwest.
PRIVATEJun 12, 2026•about 2 months ago
Amount Raised
$20 Million
Round Type
Series A
Los AngelesHealth CareE CommerceFashionBeautyLifestyleCosmeticsInvestors
NorwestSonoma Brands CapitalL Catterton
Description
Los Angeles-based REMEDY Science has successfully completed a $20 million Series A funding round, signaling confidence in its innovative skincare approach. The investment, led by L Catterton, reinforces the importance of accessible, science-backed dermocosmetic products. Industry insiders believe this capital infusion is pivotal for the company's growth and market expansion. With backing from notable investors, REMEDY is poised to redefine dermatological skincare.
Funding Insights
Based on industry dataTypical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech